Skip to content
2000
Volume 1, Issue 3
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

The use of single stereoisomers are gaining popularity in the world of anesthesiology. The reduced costs of production have made these compounds available for clinical application. The majority of drugs used in anesthesiology such as ketamine, isoflurane, etomidate, atracurium, bupivacaine and ropivacaine have an asymmetric carbon, and are still used primarily as racemic mixtures (1:1 mixture of R and S enantiomers). Among local anesthetics, the S enantiomers often have favorable biological properties. This insight has led to the development of ropivacaine. Ropivacaine is the first local anesthetic marketed as pure S-(-) enantiomer. Its pharmacodynamic and pharmacokinetic profile is similar to that of bupivacaine, but in vitro and in vivo studies have shown that ropivacaine is less cardiotoxic. Clinical data suggests that ropivacaine has a greater margin of safety than bupivacaine, which is necessary for further expanding the application of regional anesthesia. The time has come for the use of single enantiomers in regional and general anesthesia

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026013395254
2001-08-01
2025-10-04
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026013395254
Loading

  • Article Type:
    Review Article
Keyword(s): chiral drugs; Evolution; ketamine; Revolution; The Enantiomers
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test